Peripheral Vascular Devices Market Size & Growth Forecast 2026–2035, By Segments (End-use, Application, Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Peripheral Vascular Devices Market size was more than USD 10.84 Billion in 2025 and is set to grow at a 5.9% CAGR between 2026 and 2035, surpassing USD 19.23 Billion by 2035. The industry revenue for 2026 is calculated at USD 11.4 billion.

• Base Year Value (2025): USD 10.84 Billion
• CAGR (2026-2035): 5.9%
• Forecast Year Value (2035): USD 19.23 Billion
• Historical Data Period: 2022-2025
• Largest Region: North America
• Forecast Period: 2026-2035

Peripheral Vascular Devices Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America holds 41.26% share driven by widespread adoption of minimally invasive vascular procedures, high peripheral artery disease treatment volumes, and strong clinical familiarity with advanced interventional devices.
  • Asia Pacific is expanding at a 6.67% CAGR as access to vascular care improves, hospital capacity expands, and adoption of interventional treatments increases across urban and emerging healthcare systems.

• Segment Momentum:

  • Hospitals held a 62.44% share in 2025 because they manage complex vascular procedures requiring advanced imaging, multidisciplinary teams, and comprehensive post-operative care, concentrating device utilization in one setting.
  • Aneurysms are the fastest-growing application as increasing adoption of device-based vascular repair creates stronger demand for specialized endovascular solutions that support targeted treatment approaches.

• Market Expansion Drivers:

  • Increasing prevalence of peripheral arterial and venous diseases driving vascular intervention procedures.
  • Growing geriatric population accelerating demand for minimally invasive peripheral vascular treatments.
  • Advancements in catheter-based revascularization technologies improving clinical adoption of vascular devices.

• Leading Market Participants:

  Leading companies in the peripheral vascular devices market include Medtronic plc (Ireland), Abbott Laboratories (United States), Boston Scientific Corporation (United States), Koninklijke Philips N.V. (Netherlands), Edwards Lifesciences Corporation (United States), Terumo Corporation (Japan), Becton Dickinson and Company (United States), Teleflex Incorporated (United States), Cook Medical LLC (United States), W. L. Gore & Associates Inc. (United States).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2025 Market Size: USD 10.84 Billion
  • Projected Market Size: USD 19.23 Billion by 2035
  • Growth Forecasts: 5.9% CAGR (2026-2035)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Hospitals (End-use) | Peripheral Arterial Disease (PAD) (Application) | Peripheral Stents (Type)
  • Emerging Opportunity Segment: Ambulatory Surgical Centers (End-use) | Aneurysms (Application) | Peripheral Accessories (Type)

Market Growth Drivers and Industry Trends

Increasing prevalence of peripheral arterial and venous diseases driving vascular intervention procedures

Rising incidence of peripheral arterial disease, deep vein disorders, and chronic venous insufficiency is steadily increasing the volume of diagnostic and therapeutic interventions, directly reinforcing demand in the peripheral vascular devices market. As more patients present with limb ischemia, claudication, stenotic lesions, thrombotic blockages, and venous reflux, providers are moving beyond conservative management toward angioplasty, atherectomy, thrombectomy, stent placement, and embolic protection strategies that require specialized device use. This disease burden also shifts hospital and vascular center purchasing toward broader peripheral portfolios, since treating increasingly complex lesion patterns depends on access to multiple device categories rather than a single procedural tool.

Growing geriatric population accelerating demand for minimally invasive peripheral vascular treatments

An expanding elderly population is driving market development in the peripheral vascular devices market because older patients are disproportionately affected by atherosclerosis, venous disease, diabetes-related circulatory complications, and calcified peripheral lesions that often require intervention. In practice, this demographic shift is influencing treatment decisions in favor of minimally invasive approaches that reduce recovery time, procedural trauma, and hospitalization burden compared with open surgery, making catheter-based peripheral procedures more attractive to both clinicians and health systems managing frail patients with multiple comorbidities. That preference supports higher utilization of balloons, guidewires, stents, catheters, and adjunctive vascular devices used in endovascular care pathways.

Advancements in catheter-based revascularization technologies improving clinical adoption of vascular devices

Ongoing improvements in catheter-based revascularization are increasing market penetration in the peripheral vascular devices market by making endovascular treatment more practical in anatomically difficult and clinically complex cases. Better deliverability, lesion crossing capability, imaging compatibility, and device precision are allowing physicians to treat longer occlusions, heavily calcified vessels, and below-the-knee disease with greater confidence, which expands the range of patients considered suitable for intervention. As procedural performance becomes more predictable and operator workflow improves, hospitals and vascular specialists are more willing to adopt newer peripheral devices and integrate them into routine revascularization strategies.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Increasing prevalence of peripheral arterial and venous diseases driving vascular intervention procedures	2.10%	High	North America, Asia Pacific	High	Near Term
Growing geriatric population accelerating demand for minimally invasive peripheral vascular treatments	1.90%	High	Europe, North America	High	Mid Term
Advancements in catheter-based revascularization technologies improving clinical adoption of vascular devices	1.60%	High	Asia Pacific, Europe	Medium	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held the leading regional share of 41.26% in 2025 in the peripheral vascular devices market, bolstered by broad adoption of minimally invasive vascular procedures, established hospital and ambulatory care infrastructure, and consistent use of advanced diagnostic and interventional devices across clinical settings. The region’s leadership is strengthened by high procedure volumes for peripheral artery disease and related vascular conditions, along with physician familiarity with catheter-based treatment pathways that sustain demand for angioplasty balloons, stents, atherectomy systems, and related tools in routine practice.

Asia Pacific is projected to expand at a 6.67% CAGR over the forecast period, with growth in the peripheral vascular devices market being fueled by rising access to vascular care, expanding hospital capacity, and increasing use of interventional treatment as healthcare systems broaden their ability to diagnose and manage peripheral vascular disorders. Adoption is accelerating as more patients are treated in urban specialty centers, while improving procedural capabilities and growing availability of device-based therapies are translating into stronger regional demand across both established and developing healthcare markets.

Key Country Insights

United States

Minimally Invasive Care

The U.S. peripheral vascular devices market continues to prioritize minimally invasive treatment options supported by advanced imaging and catheter-based interventions. Healthcare providers in the U.S. increasingly evaluate devices that improve procedural efficiency while supporting favorable patient recovery outcomes.

Japan

Chronic Disease Management

Japan's peripheral vascular devices market is influenced by demand for effective treatment of vascular conditions associated with an aging population. Healthcare providers in Japan increasingly prioritize reliable devices that improve procedural safety and long-term clinical management of peripheral artery disease.

South Korea

Advanced Endovascular Practice

South Korea continues to expand use of peripheral vascular devices through growing adoption of advanced endovascular procedures. Hospitals in South Korea increasingly seek innovative device platforms that improve treatment accuracy and streamline complex vascular interventions.

Germany

Precision Vascular Intervention

Germany emphasizes peripheral vascular devices backed by strong clinical evidence and consistent procedural performance. Hospitals in Germany increasingly adopt technologies that enhance treatment precision, support complex vascular interventions, and integrate with established cardiovascular care pathways.

France

Evidence-Led Vascular Care

France prioritizes peripheral vascular devices that support standardized treatment protocols and high-quality cardiovascular care. Healthcare institutions in France increasingly focus on clinically validated technologies that enhance procedural outcomes while maintaining efficient hospital workflows.

Italy

Hospital Procedure Optimization

Italy's peripheral vascular devices market is supported by continued investment in endovascular treatment capabilities across specialized hospitals. Clinicians in Italy increasingly favor devices that simplify intervention procedures, improve procedural consistency, and support effective vascular disease management.

Segment Leadership and Growth Trends

  End-use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)

Hospitals held the dominant position in the peripheral vascular devices market in 2025, accounting for a 62.44% share. This leadership is underpinned by their central role in managing complex vascular cases that require advanced imaging support, multidisciplinary intervention teams, and the ability to handle higher-risk procedures and post-operative monitoring. In the peripheral vascular devices market, hospitals remain the primary setting where broad device utilization is concentrated because they can accommodate both planned interventions and urgent vascular care within a single clinical infrastructure.

Ambulatory Surgical Centers are emerging as the fastest-growing end-use segment in the peripheral vascular devices market as more suitable vascular procedures shift toward outpatient settings. Their momentum is underpinned by growing demand for efficient, lower-burden care delivery for cases that do not require extended hospitalization, making them an increasingly attractive alternative to traditional inpatient environments. Compared with hospitals, Ambulatory Surgical Centers are seeing wider adoption where procedural workflows can be streamlined without compromising treatment access, which is strengthening their growth trajectory in the market.

Application Segment Analysis: Peripheral Arterial Disease (PAD) (Largest Segment) vs Aneurysms (Fastest-Growing Segment)

Peripheral Arterial Disease (PAD) led the peripheral vascular devices market by application in 2025 with a 48.01% share. Its leadership reflects the substantial volume of device-based diagnosis and intervention tied to PAD management, where recurring need for revascularization and vessel patency support drives consistent product use across care settings. Within the peripheral vascular devices market, PAD remains the largest application because it represents a major share of routine peripheral vascular treatment activity and demands a wide range of interventional solutions.

Aneurysms represent the fastest-growing application segment in the peripheral vascular devices market, driven by increasing procedural adoption where device-based intervention is essential to treatment management. Their growth relative to other applications is underpinned by the practical need for targeted vascular repair approaches that depend heavily on specialized devices, creating stronger expansion momentum as treatment pathways become more intervention-oriented. This is making aneurysms a key area of rising demand within the market, particularly where clinicians require precise and durable endovascular solutions.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
End-use	Hospitals, Ambulatory Surgical Centers, Others	Hospitals	Ambulatory Surgical Centers
Application	Peripheral Arterial Disease (PAD), Aneurysms, Venous Diseases, Others	Peripheral Arterial Disease (PAD)	Aneurysms
Type	Peripheral Stents, PTA Balloons, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Peripheral Accessories, Inferior Vena Cava Filters, Hemodynamic Flow Alteration Devices	Peripheral Stents	Peripheral Accessories

Competitive Landscape and Market Positioning

Major players in the peripheral vascular devices market:

1. Medtronic plc (Ireland)

2. Abbott Laboratories (United States)

3. Boston Scientific Corporation (United States)

4. Koninklijke Philips N.V. (Netherlands)

5. Edwards Lifesciences Corporation (United States)

6. Terumo Corporation (Japan)

7. Becton Dickinson and Company (United States)

8. Teleflex Incorporated (United States)

9. Cook Medical LLC (United States)

10. W. L. Gore & Associates Inc. (United States)

The peripheral vascular devices market is witnessing strong momentum through the development of minimally invasive treatment technologies and advanced interventional solutions. Manufacturers are prioritizing precision-based device designs, improved catheter navigation systems, and enhanced imaging compatibility to support better clinical outcomes. Ongoing investments in next-generation vascular therapies and procedural efficiency tools are also strengthening competitive differentiation across the peripheral vascular devices market.

Industry Development/News

Company Name	Date	Key Development
Gore	Jan-25	Gore received FDA approval for the GORE VIABAHN FORTEGRA Venous Stent, the first device specifically indicated for treating deep venous disease in the inferior vena cava and iliofemoral veins. Clinical data demonstrated strong patency and safety outcomes in complex deep venous obstructions, supporting expanded treatment options in advanced venous intervention procedures.
BD	Nov-25	BD reported milestone outcomes from the AGILITY study evaluating its Revello vascular-covered stent for peripheral artery disease. The study demonstrated safety, deliverability, and potential to reduce restenosis in occluded or narrowed peripheral arteries, generating clinical evidence intended to support broader adoption in peripheral vascular intervention markets.
Boston Scientific	Sep-24	Boston Scientific completed the acquisition of Silk Road Medical, strengthening its presence in peripheral intervention devices. The transaction enhances its portfolio in peripheral angioplasty and embolic protection technologies, supporting expanded capabilities in minimally invasive vascular procedures and reinforcing its competitive positioning in the peripheral vascular devices market.
W.L. Gore & Associates	Jan-24	W.L. Gore & Associates received FDA approval for the GORE VIABAHN VBX Balloon Expandable Endoprosthesis. The regulatory clearance supports commercialization of an advanced vascular implant designed for peripheral endovascular applications, expanding Gore’s product offerings in minimally invasive vascular treatment solutions.